20+ full codes, 2,400+ articles translated and updated. Case law linked to every article. Read the actual text before you ask a lawyer about it — free, no login required.
20+
french codes
Fully translated
2,400+
articles in English
Updated regularly
480+
court rulings linked
Per article
Free
full access
No login required
Showing 3981–3990 of 69687 articles for “Art. L 225-248 and R 225-166-1”
I.-When a third party donor, within the meaning of Article L. 2143-1, is diagnosed as having a genetic anomaly which may be responsible for a serious condition justifying preventive measures, includin…
The negotiations provided for in article L. 2242-17 may also cover the prevention of the effects of exposure to the occupational risk factors provided for in article L. 4161-1. An agreement reached on…
The annual negotiations on professional equality between women and men and the quality of life and working conditions cover : 1° The balance between personal and professional life for employees ; 2° T…
Negotiations on the professional integration and continued employment of disabled workers take place on the basis of a report drawn up by the employer setting out the situation with regard to the obli…
The fees referred to in article L. 3333-8 are subject to the five-year statute of limitations which begins to run from the date on which they became due. The four-year statute of limitations institute…
As part of the pharmacovigilance system, any company or organisation exploiting a medicinal product or a product mentioned in Article R. 5121-150 : 1° Implements a risk management system for each medi…
Any company or organisation exploiting a medicinal product or a product mentioned in Article R. 5121-150 shall implement a pharmacovigilance system in order to fulfil its pharmacovigilance obligations…
Any company or organisation exploiting a medicinal product or a product referred to in Article R. 5121-150 has at its disposal on a permanent basis the services of a person responsible for pharmacovig…
The holder of the authorisation provided for in Article L. 4211-6 is required to report the following to the Director General of the Agence nationale de sécurité du médicament et des produits de santé…
The company or organisation exploiting a medicinal product or a product referred to in Article R. 5121-150 may not communicate information relating to pharmacovigilance to the general public about thi…
Avocate au Barreau de Paris
Toque #C2396
15+ Years In French Corporate Practice
English · French · Russian
Ready When You Are
A 20–30 minute call, in English, to scope the engagement. No obligation, no preliminary fee. You will leave the call with a clear view of what the work will cover and what it will cost.
20+ full codes and 2,400+ articles in English, with the key court rulings linked to every article — free to read.
Read MoreA lawyer-reviewed report explaining how the relevant articles apply to your situation, with case-law analysis and next steps.
Read MoreScope your matter with a Paris-Bar avocate — incorporation, contracts, disputes — handled bilingually, end to end.
Read More
